REDOX Health Group

Functional Medicine Testing

Home

REDOX FxMed Laboratory

Functional Medicine Testing

FUNCTIONAL MEDICINE TESTING INFORMATION

More Testing Info

Metabolic System

Endocrine System

Nutrition System

Environmental Toxins

Immune System

Gastrointestinal System

Predictive Genomics

SAMPLE REPORT

1439 Methyl Genomics® (Blood)

Testing for health and disease-related Single-Nucleotide Polymorphisms (SNPs) can increase the success rate of clinical disease diagnosis and preventive treatments, providing clients with a more comprehensive health management plan.
Methyl Genomic® analysis helps clinicians diagnose congenital genetic predispositions and assess whether biochemical methylation pathways are functioning properly in the body. These methylation cycles include the methionine cycle, folate cycle, biopterin (BH4) cycle, urea cycle, and citric acid cycle, all of which are interconnected reactions.
The presence or absence of SNPs can alter disease risk. By testing 30 mutation points in 13 methylation cycle genes, we can optimize imbalanced physiological functions in the body to an optimal state through lifestyle adjustments, dietary modifications, and personalized nutrigenomics prescriptions.

SAMPLE REPORT

Testing Content

Single-Nucleotide Polymorphism, SNPs
Single-Nucleotide Polymorphisms (SNPs) are changes in the DNA sequence where a single base pair, such as A, T, C, or G, is replaced by another. SNPs are the most common type of genetic variation, with an occurrence rate of approximately 0.1%. Since each person’s SNPs are unique, they can serve as genetic markers. Research has been exploring the correlation between specific SNPs or combinations of SNPs and particular diseases, leading to more precise disease diagnosis and the development of personalized medical strategies.


Methylation cycle gene functions can be assessed as follows
Insulin sensitivityCancer risk
Bone healthCardiovascular health
Detoxification capacityMethylation efficiency
Mitochondrial function and metabolismNeurotransmitter balance

Applications of Methyl Genomics® Testing

  • Methionine Cycle
    S-adenosylmethionine (SAMe) is a key methyl donor in this cycle, supplying methyl groups (–CH₃) for over 400 methylation reactions. It not only provides substrates for the folate cycle but is also closely linked to liver detoxification and the urea cycle. The methionine cycle directly influences overall methylation status and is closely associated with individual personality traits.
  • Folate Cycle
    This cycle indirectly or directly regulates the metabolism of homocysteine. Impaired gene function in this pathway can lead to severe inflammation in the heart, brain, and blood vessels, and is associated with conditions such as multiple sclerosis, osteoporosis, dyslipidemia, and diabetes.
  • BH4 Cycle
    Responsible for the production of neurotransmitters, this cycle facilitates communication between nerves and cells, helping the body respond to major stress, emotional changes, and regulate sleep cycles. Dysfunction in this cycle can lead to emotional imbalances such as ADHD, OCD, insomnia, depression, and anxiety.
  • Urea Cycle
    This cycle eliminates urea, a byproduct of protein metabolism, while recycling useful substances and producing nitric oxide to help prevent cardiovascular disease. It also supplies intermediates for the citric acid cycle. When the urea cycle is impaired, urea can accumulate in the body, leading to abnormal gut flora and potential toxicity due to the inability to metabolize sulfur compounds.
  • Citric Acid Cycle
    This is a crucial mitochondrial cycle that converts food into cellular energy (ATP). Genetic defects in this cycle can lead to gastrointestinal disorders, developmental delays, metabolic syndrome, or mitochondrial dysfunction. More than half of individuals with autism or chronic fatigue syndrome show signs of mitochondrial dysfunction.

The important information provided by Methyl Genomics® is as follows

  • We believe that anyone with a health-conscious mindset should undergo Methylation Cycle Gene Testing (Methyl Genomics®) as a foundational tool for precisely planning personalized nutritional strategies.
  • Methylation cycle gene testing, combined with related metabolomics testing, provides physicians with clear clinical insights into a client’s overall health status, integrating both genetic predispositions and current metabolic conditions.
  • Clinical issues and symptoms related to methylation cycle genes include: hypo- or hypermethylation personality traits, homocysteine and cardiovascular risk, endothelial function, transsulfuration capacity and brain fog, protein metabolism and urea excretion, liver and kidney function, stroke, cancer, vitamin D metabolism needs, emotional imbalances, liver detoxification, and mitochondrial energy production.
  • By testing for individual gene variations, we can better understand one’s inherent susceptibility to certain conditions. A gene variation may increase vulnerability to certain chronic diseases, but it does not guarantee disease development. This is because gene expression is not fixed; it can change based on environmental factors and dietary habits.
  • Analyzing methylation cycle genes helps physicians develop personalized health management plans, using nutritional supplements to support and improve vital methylation processes in the body.
  • Almost every person tested will show some genetic mutations in their methylation cycle genes—without exception. However, these mutations often go unnoticed and are not immediately linked to physical discomfort, which is why preventive testing and proactive health management are so valuable.
  • As we face an aging society, it's essential to proactively engage in early health management, anti-aging strategies, immune enhancement, and age gracefully and healthily—ultimately reducing the burden on our families and society.